Medication Management

Introduction

Venlafaxine is a serotonin and norepinephrine reuptake inhibitor (SNRI) used for various indications, including hot flashes, neuropathic pain, and depression, as supported by the National Comprehensive Cancer Network and the American Diabetes Association 1, 2

The recommended starting dose of venlafaxine is 37.5-75 mg/day, with a maximum recommended dose of 225 mg/day for outpatients, and dose increments should not exceed 75 mg/day, with a minimum interval of 4 days between increases, as recommended by the National Comprehensive Cancer Network and the American Diabetes Association 1, 2
When initiating venlafaxine or adjusting doses, start at a lower dose and gradually increase to the target dose, allowing 1 week between dose adjustments to assess side effects, as recommended by the National Comprehensive Cancer Network 1
Consider reducing the dose if clinically appropriate, and ensure dose increments do not exceed 75 mg/day, with a minimum interval of 4 days between increases, although the exact dosing schedule may vary depending on the patient's response and tolerability 1, 2

The following dose ranges are recommended for specific indications:

Indication	Recommended Dose
Painful diabetic neuropathy	150-225 mg/day, as recommended by the American Diabetes Association [2]
Neuropathic pain management	75-225 mg/day, as recommended by the National Comprehensive Cancer Network [3]
Hot flashes	Start at 37.5 mg and increase to 75 mg after 1 week if needed, as recommended by the National Comprehensive Cancer Network and the European Society for Medical Oncology [1, 4]

Venlafaxine appears effective for management of hot flashes in breast cancer patients, with moderate strength of evidence, as supported by the American Society of Clinical Oncology 4
The use of venlafaxine for chemotherapy-induced peripheral neuropathy is not recommended for routine clinical practice due to inadequate evidence, according to the American Society of Clinical Oncology 5
Common side effects of venlafaxine include nausea, sedation, dizziness, dry mouth, and sweating, which may increase in frequency and severity at higher doses, and may also include sexual dysfunction, such as erection problems and delayed ejaculation, as noted by the American Urological Association 3, 1, 4

Venlafaxine has less impact on CYP2D6 than some SSRIs, such as paroxetine and fluoxetine, which is important for patients taking tamoxifen, as noted by the National Comprehensive Cancer Network 4
Patients with hepatic impairment may require a 50% reduction in the total daily dose of venlafaxine, as recommended by the American Association for the Study of Liver Diseases 2
Patients with renal impairment may require a 25-50% reduction in the dose of venlafaxine, depending on the severity of renal impairment, as recommended by the National Kidney Foundation 2
Elderly patients may require caution when increasing the dose of venlafaxine, but no specific dose adjustment is needed based on age alone, as recommended by the American Geriatrics Society 2
Regularly monitor blood pressure, especially when increasing doses of venlafaxine, as the risk of hypertension increases at doses >150 mg/day, as recommended by the American Heart Association 2
Avoid abrupt discontinuation of venlafaxine, as it can lead to withdrawal symptoms, including dizziness, sensory disturbances, anxiety, and insomnia, and consider tapering the dose gradually to minimize the risk of withdrawal symptoms 1

Rule out other causes of drowsiness, including sleep disorders, using tools like the Epworth Sleepiness Scale, as suggested by the National Comprehensive Cancer Network 6
Monitor patients closely, especially elderly patients, who may be more sensitive to the sedating effects of venlafaxine, and consider referral to a sleep specialist if drowsiness persists despite appropriate management strategies 1
Consider switching to an alternative antidepressant with a different side effect profile if drowsiness remains intolerable despite adjustments, such as SSRIs, which may have a more favorable side effect profile for some patients 1
Take venlafaxine at bedtime rather than in the morning to align the sedative effects with normal sleep patterns, and consider adjusting the dose or switching to an alternative antidepressant if drowsiness persists, as recommended by the National Comprehensive Cancer Network 1